Longitudinal associations between changes in bone mechanical strength and fracture risk estimated by μFRAC

μFRAC 估计的骨骼力学强度变化与骨折风险之间的纵向关联

阅读:2

Abstract

Monitoring bone health for osteoporosis is typically based on measuring areal BMD. However, widely used fracture risk prediction tools are primarily driven by clinical risk factors and show limited sensitivity to underlying bone changes over time. This study evaluated the ability of the new Microarchitecture Fracture Risk Assessment Calculator ($\mu $FRAC) to detect longitudinal changes in fracture risk in relation to bone quality. Our study cohort included 601 participants (70.2% female) from a longitudinal population study. HR-pQCT scans of the distal radius and tibia were acquired at 2 visits, 3-10 years apart. The $\mu $FRAC 5-year risk of major osteoporotic fracture was calculated at both time points. Participants were divided into quartiles based on the absolute change in tibia bone strength between study visits to assess the model's sensitivity to changes in bone fragility. Differences between quartiles were assessed using a Mann-Whitney U test and the standardized response mean (SRM). Additionally, changes in fracture risk by decade, were analyzed to investigate age- and sex-specific trends in fracture risk. The average age of participants was 53.8 $\pm $ 15.4 years, with an average follow-up of 6.8 $\pm $ 1.8 years. The greatest absolute annualized changes in $\mu $FRAC risk occurred in individuals with the largest differences in bone strength (SRM = 0.73-0.78), while the least change was observed in individuals with minimal changes (SRM = 0.07-0.21). Age- and sex-specific trends aligned with previously established patterns of bone aging, showing the greatest annualized changes in fracture risk in menopausal females (40-60 years) and older adults (70+ years). We demonstrated $\mu $FRAC is sensitive to changes in fracture risk driven by declines in bone quality in aging adults. These results suggest $\mu $FRAC is well suited for tracking fracture prediction longitudinally and has potential to monitor osteoporosis disease progression and treatment response.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。